Map, active in consulting and market access services, is acquired by PharmaLex, a multinational leader in services for the pharmaceutical, biotechnology and medtech industries.
The MAP group, founded in 2010 by Elena Paola Lanati, includes three companies, Ma Provider, Mapcom Consulting and 3P Solution, which offer high quality skills and services throughout the product life cycle (from the negotiation strategy to the market launch , at local access). The team of over 70 consultants of the Map group supports the market entry of a significant number of new drugs, providing an integrated strategy of market access, public affairs, brand communication and ECM projects.
The Group deals with innovative products, including advanced therapies (Atmp), drugs for rare diseases and oncology. Map is one of the founders of the Atmp Forum project, the first specific study center founded in 2017 to allow all system players to discuss and exchange views on the development and future of ATMs. “The merger with PharmaLex perfectly complements the service offering, and leverages our strong local market knowledge and expertise, while providing our customers with a global market vision,” said Elena Paola Lanati who is confirmed as CEO of Map. and, at the same time, becomes a shareholder of PharmaLex.
The entire leadership team of the group was also confirmed in their role. «We share common principles and values with PharmaLex, supporting our customers to operate in an increasingly complex regulatory and commercial environment, and at the same time working to ensure that Map becomes a global market leader. Furthermore, the merger with PharmaLex offers the opportunity for our talents to grow professionally in a global market ».
Thomas Dobmeyer, CEO of PharmaLex, is pleased to «welcome the Map group team to PharmaLex and we are excited about the opportunity to further expand our offer in the market access, public affairs, brand communication and medical education sectors. The merger also allows us to extend our presence in the strategic Italian market, strengthening the team already present in Milan, focused on regulatory, safety and quality affairs. PharmaLex has been present in Italy since 2017 and has already consolidated a strong local connotation. The merger with the Map group further strengthens our global team and allows us to guarantee our customers constant support throughout the product life cycle, with excellent tailor-made results ».